Enzymotec (ENZY) Misses Q2 EPS by 2c, Beats on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
UPDATE: Paulson's 13F Shows New Hertz (HTZ) Puts, Stake in Horizon Pharma (HZNP), (More...)
August 14, 2017 5:32 PM EDT(Updated - August 14, 2017 5:34 PM EDT)
Paulson & Co filed its 13F for the quarter ended June 2017. Below is a summary.
New Stakes
Albany Molecular Research, Inc. (NASDAQ: AMRI) new 314,200 share position
Apple Inc. (NASDAQ: AAPL) new 12,300 share position
Bard (C.R.) Inc. (NYSE: BCR) new 42,122 share position
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) new 349,500 share position
Blueprint Medicines (NASDAQ: BPMC) new 65,800 share position
Ctrip.com International, Ltd. (NASDAQ: CTRP) new 173,200 share position
Entellus... More
